Gregory J. Moran

Olive View-UCLA Medical Center — United States

Medicine · Health Sciences

44h-index15.9kcitations996works4.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antimicrobial Resistance in Staphylococcus(45), Streptococcal Infections and Treatments(38), Bacterial Identification and Susceptibility Testing(31), Pneumonia and Respiratory Infections(23), Bacillus and Francisella bacterial research(19)

Publications315 total

P-815. A Randomized Trial of Doxycycline vs. Trimethoprim Sulfamethoxazole (TMP-SMX) for Uncomplicated Skin and Skin Structure Infections (SSSIs)
Open Forum Infectious Diseases·2026Open Access
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Duration of Antibiotics for Complicated UTI
Clinical Infectious Diseases·2025
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Timing of Intravenous to Oral Antibiotics Transition for Complicated UTI
Clinical Infectious Diseases·2025· 1 cited
Clinical Practice Guideline by Infectious Diseases Society of America (IDSA): 2025 Guideline on Management and Treatment of Complicated Urinary Tract Infections: Introduction and Methods
Clinical Infectious Diseases·2025
Presenteeism Among Health Care Personnel With COVID-19
JAMA Network Open·2025Open Access
Nonoperative Treatment of Appendicitis and Implications for Emergency Department Management: A Narrative Review
Annals of Emergency Medicine·2025· 1 citedOpen Access
Mpox Surveillance Based on Rash Characteristics — 13 Emergency Departments, United States, June–December 2023
MMWR Morbidity and Mortality Weekly Report·2024· 3 citedOpen Access
Race, Ethnicity, and Delayed Time to COVID-19 Testing Among US Health Care Workers
JAMA Network Open·2024· 4 citedOpen Access
Coronavirus Disease 2019 Infections Among Emergency Health Care Personnel: Impact on Delivery of United States Emergency Medical Care, 2020
Annals of Emergency Medicine·2024Open Access
Exebacase in Addition to Standard-of-Care Antibiotics for <i>Staphylococcus aureus</i> Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT)
Clinical Infectious Diseases·2024· 35 citedOpen Access
Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US Healthcare Personnel, October 2021–July 2022
Open Forum Infectious Diseases·2023· 8 citedOpen Access
Trial Participation and Outcomes Among English-Speaking and Spanish-Speaking Patients With Appendicitis Randomized to Antibiotics
JAMA Surgery·2023· 5 citedOpen Access
Association of Patient Belief About Success of Antibiotics for Appendicitis and Outcomes
JAMA Surgery·2022· 13 citedOpen Access
Analysis of Outcomes Associated With Outpatient Management of Nonoperatively Treated Patients With Appendicitis
JAMA Network Open·2022· 48 citedOpen Access
Self-selection vs Randomized Assignment of Treatment for Appendicitis
JAMA Surgery·2022· 30 citedOpen Access
Lefamulin Efficacy and Safety in Adults with Community-Acquired Bacterial Pneumonia (CABP): Pooled Analysis of the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Trials in Patients with Asthma or Chronic Obstructive Lung Disease (COPD)
2022
A Plain Language Summary of How Lefamulin Alone Can Be Used to Treat Pneumonia Caught Outside of the Hospital Due to common bacterial causes, including drug-Resistant bacteria
Future Microbiology·2022· 3 citedOpen Access
Patient Factors Associated With Appendectomy Within 30 Days of Initiating Antibiotic Treatment for Appendicitis
JAMA Surgery·2022· 64 citedOpen Access
Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs
Infectious Diseases and Therapy·2022· 9 citedOpen Access
Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials
Antibiotics·2021· 11 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

David A. Talan(34), Anusha Krishnadasan(17), Fredrick M. Abrahamian(15), Mark T. Steele(8), William R. Mower(7), Richard E. Rothman(7), Frank LoVecchio(6), Lisandra Uribe(5), Sukhjit S. Takhar(5), Darin J. Saltzman(5), Rachel Gorwitz(4), David J. Karras(4), Elizabeth Krebs(4), Brett Faine(4), Samuel Ong(4), Janet Nakase(4), Daniel A. DeUgarte(4), Kavitha Pathmarajah(4), Thomas M. Hooton(3), Sara E. Cosgrove(3)